Clinical Trial Update: Darbepoetin in Patients Candidates for Liver Transplant. (EPO-LT Trial) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating darbepoetin in patients who are candidates for liver transplantation is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease

Drugs mentioned

• ARANESP (DARBEPOETIN ALFA)

Snippet

Sponsor: Fundacion Clinic per a la Recerca Biomédica | Conditions: Liver Transplant; Complications | Phase 3 | Status: RECRUITING